DATE [JIAYUAN.COM INTERNATIONAL] 6-K: Jiayuan Announces Annual Dividend of 24c per ADS

[Jiayuan Announces Annual Dividend of 24c per ADS BEIJING, March 6, 2014 /PRNewswire/ — Jiayuan.com International Ltd. (“Jiayuan”) (NASDAQ: DATE), operator of the largest online dating platform in China, today announced that its Board of Directors has declared an annual cash dividend in the amount of US$0.16 per ordinary share or US$0.24 per American Depositary Share (“ADS”), payable to record] [333-173619 JIAYUAN.COM INTERNATIONAL LTD. F/15, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China (8610) 6113-6312 Form 20-F o Form 40-F o ¨ ¨ Yes o No x O n March 6 2]

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng

[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan Dr. S.K. Chen ChipMOS TECHNOLOGIES (Bermuda) LTD. +886-6-507-7712 s.k._chen@chipmos.com In the U.S. David Pasquale]

By | 2016-03-17T16:44:29+00:00 March 10th, 2014|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: (Original Filing)

[Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 1,227,075 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 1,227,075 Item 8: Shared Dispositive Power: 0 Item]

VNET [21Vianet] SC 13G: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 20,480,508 Item 6: 0 Item 7: 21,225,108 Item 8: 0 Item 9: 21,225,108 Item 11: 7.501% Item 12: HC Cusip #90138A921 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 21,225,108 Item 8: 0 Item 9: 21,225,108 Item 11: 7.501%]

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391

[Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 1,227,075 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 1,227,075 Item 8: Shared Dispositive Power: 0 Item]

By | 2016-03-28T03:57:50+00:00 March 10th, 2014|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: , , , , , |0 Comments

VNET [21Vianet] 6-K/A: (Original Filing)

[21Vianet Group, Inc. Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results 4Q13 Net Revenues Up 30.6% YOY to RMB545.9 Million 4Q13 Adjusted EBITDA Up 31.4% YOY to RMB102.9 Million Live Conference Call to be Held at 8:00 PM U.S. Eastern Time, March 6, 2014 BEIJING, March 6, 2014 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or] [EXPLANATORY NOTE 21Vianet Group, Inc. By : Shang-Wen Hsiao Chief Financial Officer Press Release 6-K/A 1 d688339d6ka.htm AMENDMENT NO. 1 TO FORM 6-K]

BSPM [Biostar Pharmaceuticals] 424B5: (Original Filing)

[Prospectus Supplement To Prospectus Dated December 31, 2013 Registration No. 333-192963 Biostar Pharmaceuticals, Inc. 1,650,000 shares of common stock Our shares of common stock are currently traded on the Nasdaq Capital Market under the symbol “BSPM.” On March 7, 2014, the closing sale price of our shares of common stock was $2.97 per share. Risk Factors Investing in our securities]

By | 2016-03-28T18:37:11+00:00 March 10th, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

VNET [21Vianet] 6-K/A: 21Vianet Group, Inc. Reports Unaudited Fourth Quarter and

[21Vianet Group, Inc. Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results 4Q13 Net Revenues Up 30.6% YOY to RMB545.9 Million 4Q13 Adjusted EBITDA Up 31.4% YOY to RMB102.9 Million Live Conference Call to be Held at 8:00 PM U.S. Eastern Time, March 6, 2014 BEIJING, March 6, 2014 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or] [EXPLANATORY NOTE 21Vianet Group, Inc. By : Shang-Wen Hsiao Chief Financial Officer Press Release 6-K/A 1 d688339d6ka.htm AMENDMENT NO. 1 TO FORM 6-K]

BSPM [Biostar Pharmaceuticals] 424B5: Prospectus Supplement To Prospectus Dated December 31, 2013

[Prospectus Supplement To Prospectus Dated December 31, 2013 Registration No. 333-192963 Biostar Pharmaceuticals, Inc. 1,650,000 shares of common stock Our shares of common stock are currently traded on the Nasdaq Capital Market under the symbol “BSPM.” On March 7, 2014, the closing sale price of our shares of common stock was $2.97 per share. Risk Factors Investing in our securities]

By | 2016-03-28T18:38:43+00:00 March 10th, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar